Rethinking the Effectiveness of Paxlovid, the Anti-Covid Pill

The emergency use authorization for this drug was based upon flawed and limited research by the company that makes it.

Courtesy of gettyimages.com (Note: this image does not represent Paxlovid pills)

Last December, the FDA granted emergency use authorization to Pfizer for its oral anti-viral drug, Paxlovid, to treat Covid in high-risk individuals. The claim was the drug was “88% effective in reducing Covid-related hospitalizations and…

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
David Mokotoff

David Mokotoff

David Mokotoff is a retired MD. Passionate about writing, reading, fishing, and food, https://tinyurl.com/y7bjoqkd